1. Bacteriocin ASM1 is an O / S ‐diglycosylated, plasmid‐encoded homologue of glycocin F
- Author
-
Trevor S. Loo, Gillian E. Norris, Vladimír Havlíček, Patrick Main, Tomomi Hata, Petr Man, Mark L. Patchett, and Petr Novák
- Subjects
Glycosylation ,Biophysics ,Biochemistry ,Genome ,03 medical and health sciences ,Plasmid ,Bacteriocins ,Bacteriocin ,Structural Biology ,Genetics ,Amino Acid Sequence ,Molecular Biology ,Gene ,IC50 ,Phylogeny ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Base Sequence ,biology ,030302 biochemistry & molecular biology ,Prokaryote ,Sequence Analysis, DNA ,Cell Biology ,biology.organism_classification ,Amino acid ,chemistry ,Genes, Bacterial ,Novobiocin ,Lactobacillus plantarum ,Plasmids - Abstract
Here, we report on the biochemical characterization of a new glycosylated bacteriocin (glycocin), ASM1, produced by Lactobacillus plantarum A-1 and analysis of the A-1 bacteriocinogenic genes. ASM1 is 43 amino acids in length with Ser18-O- and Cys43-S-linked N-acetylglucosamine moieties that are essential for its inhibitory activity. Its only close homologue, glycocin F (GccF), has five amino acid substitutions all residing in the flexible C-terminal 'tail' and a lower IC50 (0.9 nm) compared to that of ASM1 (1.5 nm). Asm/gcc genes share the same organization (asmH← →asmABCDE→F), and the asm genes reside on an 11 905-bp plasmid dedicated to ASM1 production. The A-1 genome also harbors a gene encoding a 'rare' bactofencin-type bacteriocin. As more examples of prokaryote S-GlcNAcylation are discovered, the functions of this modification may be understood.
- Published
- 2020
- Full Text
- View/download PDF